Harnessing formulation and clinical pharmacology knowledge for efficient pediatric drug development: Overview and discussions from M-CERSI pediatric formulation workshop 2019

• Published in: European journal of pharmaceutics and biopharmaceutics Vol. 164; pp. 66 - 74
• Main Authors: Khong, Yuet Mei, Liu, Jing, Cook, Jack, Purohit, Vivek, Thompson, Karen, Mehrotra, Shailly, Cheung, S.Y. Amy, Hay, Justin L., Fletcher, Elimika Pfuma, Wang, Jian, Sachs, Hari Cheryl, Zhu, Hao, Siddiqui, Akhtar, Cunningham, Lea, Selen, Arzu
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.07.2021
• Subjects: Age-appropriate formulation; Clinical pharmacology; Drug development; Pediatric; Pharmacokinetics; Clinical pharmacology; Drug development; Pharmacokinetics; Pediatric; Age-appropriate formulation; age-appropriate formulation; drug development; pharmacokinetics; clinical pharmacology; pediatric
• ISSN: 0939-6411; 1873-3441; 1873-3441
• DOI: 10.1016/j.ejpb.2021.04.010

[Display omitted] A pediatric formulation workshop entitled “Pediatric Formulations: Challenges of Today and Strategies for Tomorrow” was held to advance pediatric drug product development efforts in both pre-competitive and competitive environments. The workshop had four main sessions discussing key considerations of Formulation, Analytical, Clinical and Regulatory. This paper focuses on the clinical session of the workshop. It provides an overview of the discussion on the interconnection of pediatric formulation design and development, clinical development strategy and pediatric clinical pharmacology. The success of pediatric drug product development requires collaboration of multi-disciplinary teams across the pharmaceutical industry, consortiums, foundations, academia and global regulatory agencies. Early strategic planning is essential to ensure alignment among major stakeholders of different functional teams. Such an alignment is particularly critical in the collaboration between formulators and clinical pharmacology teams.